Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: J Immunol. 2022 Sep 16;209(9):1788–1795. doi: 10.4049/jimmunol.2200245

Figure 2. FBXO3 and FBXL2 and expressed in airway epithelia and mononuclear cells during mouse acute rejection.

Figure 2.

(A)(C) Immunohistochemical staining of FBXO3 and FBXL2 in isografts (B6→B6) (left column), allografts (BALB/c→B6) (middle column) and allografts with MR1-CTLA4Ig treatment (right column). (B)(D) Densitometry analysis of Immunohistochemical staining of FBXO3 and FBXL2 for (A) & (C). Data are representative of n= 4 mice/group.